Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial. (2023)
Attributed to:
The impact of maternal infection with Mycobacterium tuberculosis on the infant response to BCG immunisation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00068-3
PubMed Identifier: 37060917
Publication URI: http://europepmc.org/abstract/MED/37060917
Type: Journal Article/Review
Volume: 23
Parent Publication: The Lancet. Infectious diseases
Issue: 8
ISSN: 1473-3099